-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2019 to Q1 2023.
- Ambrx Biopharma Cayman, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2023 was -$13M, a 49.5% increase year-over-year.
- Ambrx Biopharma Cayman, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$68.7M, a 53.8% decline from 2021.
- Ambrx Biopharma Cayman, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$44.6M, a 117% decline from 2020.
- Ambrx Biopharma Cayman, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$20.6M, a 644% decline from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)